Niklas Mejhert

Niklas Mejhert

Auto-generated profile, based on publicly available information

Niklas Mejhert

Department of Medicine Huddinge (H7), Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2015 in Science
Verified
Journal Article
Closed access
PDF file
EAErik Arner
Erik Arner
CDCarsten O. Daub
Carsten O. Daub
KVKristoffer Vitting-Seerup
Kristoffer Vitting-Seerup
RARobin Andersson
Robin Andersson
BLBerit Lilje
Berit Lilje
YHYoshihide Hayashizaki
Yoshihide Hayashizaki
Uncaging promoter and enhancer dynamics: In order to understand cellular differentiation, it is important to understand the timing of the regulation of gene expression. Arner et al. used cap analysis of gene expression (CAGE) to analyze gene enhancer and promoter activities in a number of human and mouse cell types. The RNA of enhancers was transcribed first, followed by that of transcription factors, and finally by genes that are not transcription factors. Science , this issue p. 1010

21 August 2017 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TCThe FANTOM Consortium
The FANTOM Consortium
DRDerek de Rie
Derek de Rie
IAImad Abugessaisa
Imad Abugessaisa
Tanvir AlamTanvir Alam
Tanvir Alam
EAErik Arner
Erik Arner
MHMichiel J L de Hoon
Michiel J L de Hoon

1 August 2017 in Cell Metabolism
Verified
Journal Article
Closed access
CCChandramohan Chitraju
Chandramohan Chitraju
NMNiklas Mejhert
Niklas Mejhert
JHJoel T. Haas
Joel T. Haas
LDL. Grisell Diaz-Ramirez
L. Grisell Diaz-Ramirez
CGCarrie A. Grueter
Carrie A. Grueter
RFRobert V. Farese
Robert V. Farese

18 November 2024 in Nature
Verified
Journal Article
Open access
PDF file
LHLaura C. Hinte
Laura C. Hinte
DCDaniel Castellano-Castillo
Daniel Castellano-Castillo
AGAdhideb Ghosh
Adhideb Ghosh
KMKate Melrose
Kate Melrose
EGEmanuel Gasser
Emanuel Gasser
FMFerdinand von Meyenn
Ferdinand von Meyenn
Reducing body weight to improve metabolic health and related comorbidities is a primary goal in treating obesity1,2. However, maintaining weight loss is a considerable challenge, especially as the body seems to retain an obesogenic memory that defends against body weight changes3,4. Overcoming this barrier for long-term treatment success is difficult because the molecular mechanisms underpinning this phenomenon remain largely unknown. Here, by using single-nucleus RNA sequencing, we show that both human and mouse adipose tissues retain cellular transcriptional changes after appreciable weight loss. Furthermore, we find persistent obesity-induced alterations in the epigenome of mouse adipocytes that negatively affect their function and response to metabolic stimuli. Mice carrying this obesogenic memory show accelerated rebound weight gain, and the epigenetic memory can explain future transcriptional deregulation in adipocytes in response to further high-fat diet feeding. In summary, our findings indicate the existence of an obesogenic memory, largely on the basis of stable epigenetic changes, in mouse adipocytes and probably other cell types. These changes seem to prime cells for pathological responses in an obesogenic environment, contributing to the problematic ‘yo-yo’ effect often seen with dieting. Targeting these changes in the future could improve long-term weight management and health outcomes.

17 July 2012 in Diabetes
Verified
Journal Article
Open access
PDF file
EAErik Arner
Erik Arner
NMNiklas Mejhert
Niklas Mejhert
AKAgné Kulyté
Agné Kulyté
PBPiotr J. Balwierz
Piotr J. Balwierz
MPMikhail Pachkov
Mikhail Pachkov
PAPeter Arner
Peter Arner
In obesity, white adipose tissue (WAT) inflammation is linked to insulin resistance. Increased adipocyte chemokine (C-C motif) ligand 2 (CCL2) secretion may initiate adipose inflammation by attracting the migration of inflammatory cells into the tissue. Using an unbiased approach, we identified adipose microRNAs (miRNAs) that are dysregulated in human obesity and assessed their possible role in controlling CCL2 production. In subcutaneous WAT obtained from 56 subjects, 11 miRNAs were present in all subjects and downregulated in obesity. Of these, 10 affected adipocyte CCL2 secretion in vitro and for 2 miRNAs (miR-126 and miR-193b), regulatory circuits were defined. While miR-126 bound directly to the 3′-untranslated region of CCL2 mRNA, miR-193b regulated CCL2 production indirectly through a network of transcription factors, many of which have been identified in other inflammatory conditions. In addition, overexpression of miR-193b and miR-126 in a human monocyte/macrophage cell line attenuated CCL2 production. The levels of the two miRNAs in subcutaneous WAT were significantly associated with CCL2 secretion (miR-193b) and expression of integrin, α-X, an inflammatory macrophage marker (miR-193b and miR-126). Taken together, our data suggest that miRNAs may be important regulators of adipose inflammation through their effects on CCL2 release from human adipocytes and macrophages.

29 August 2017 in Scientific Data
Verified
Journal Article
Open access
PDF file
SNShuhei Noguchi
Shuhei Noguchi
TATakahiro Arakawa
Takahiro Arakawa
SFShiro Fukuda
Shiro Fukuda
MFMasaaki Furuno
Masaaki Furuno
AHAkira Hasegawa
Akira Hasegawa
YHYoshihide Hayashizaki
Yoshihide Hayashizaki
In the FANTOM5 project, transcription initiation events across the human and mouse genomes were mapped at a single base-pair resolution and their frequencies were monitored by CAGE (Cap Analysis of Gene Expression) coupled with single-molecule sequencing. Approximately three thousands of samples, consisting of a variety of primary cells, tissues, cell lines, and time series samples during cell activation and development, were subjected to a uniform pipeline of CAGE data production. The analysis pipeline started by measuring RNA extracts to assess their quality, and continued to CAGE library production by using a robotic or a manual workflow, single molecule sequencing, and computational processing to generate frequencies of transcription initiation. Resulting data represents the consequence of transcriptional regulation in each analyzed state of mammalian cells. Non-overlapping peaks over the CAGE profiles, approximately 200,000 and 150,000 peaks for the human and mouse genomes, were identified and annotated to provide precise location of known promoters as well as novel ones, and to quantify their activities.